Jin, Q., Zheng, J., Chen, M., Jiang, N., Xu, X., & Huang, F. (2021). HIF-1 Inhibitor YC-1 Reverses the Acquired Resistance of EGFR-Mutant HCC827 Cell Line with MET Amplification to Gefitinib. Oxid Med Cell Longev.
Citação norma ChicagoJin, Qian, Jisheng Zheng, Ming Chen, Na Jiang, Xianrong Xu, and Feihua Huang. "HIF-1 Inhibitor YC-1 Reverses the Acquired Resistance of EGFR-Mutant HCC827 Cell Line With MET Amplification to Gefitinib." Oxid Med Cell Longev 2021.
Citação norma MLAJin, Qian, et al. "HIF-1 Inhibitor YC-1 Reverses the Acquired Resistance of EGFR-Mutant HCC827 Cell Line With MET Amplification to Gefitinib." Oxid Med Cell Longev 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.